
Richo and Jones interviews Clive Palmer; thanks him for his generous hydroxychloroquine donation to the nation
Watch the video“Clive, we’re very grateful.” In an interview with Clive Palmer, Alan Jones teases
Watch the video“Clive, we’re very grateful.” In an interview with Clive Palmer, Alan Jones teases
Source: Research Gate SHOUMAN WM1, HEGAZY AA2, NAFAE RM3, RAGAB ME4, SAMRA SR5, ANAS D6,
In this study of COVID-19, for infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization
Maintaining an average hydroxychloroquine whole blood level above 1,068 ng/mL significantly reduced the risk of thrombosis in adults with systemic lupus.
HCQ is effective for COVID-19. The chance that an ineffective treatment generated results as positive as the 187 studies to date is 1 in 5 quadrillion (p = 0.00000000000000019).
Source: PubMed Petri M, Konig MF, Li J, Goldman DW. Higher Hydroxychloroquine Blood Levels Are
Hydroxychloroquine is an effective molecule against COVID-19 infection, many RCTs and observational studies, affirmed the benefits on virological clearance.
No cases of sudden death were observed. From publication, we have treated 3,119 patients with HCQ-AZ for at least three days.
Early SMDT (sequenced multidrug therapy) should be a standard practice in high risk & severely symptomatic acute COVID-19 patients at the onset of illness.
The early use of
hydroxychloroquine decreased the improvement time
and the duration of COVID-19 detection in throat and
stool swabs.
Adjunct Prof John SkerrittDeputy SecretaryHealth Products Regulation GroupJohn.Skerritt@health.gov.auGPO Box 9848, Canberra, ACT Dear Professor Skerritt,We
Source: HCQMeta.com HCQ is effective for COVID-19 when used early: meta-analysis of 156 studies (Version
Source: Research Square. Methods This study was conducted according to the recommendations outlined in the
Source: MedRxIV David M. Wiseman, Pierre Kory, Samir A Saidi, Dan Mazzucco doi: https://doi.org/10.1101/2020.11.29.20235218 Abstract BACKGROUND A recent trial (NCT04308668) found that post-exposure
Source: AAPS Online Senior Editor:Jane Orient, MD, Internal Medicine Physician, Executive Director,Association of American Physicians
Source: America’s Frontline Doctors THIS IS NOT MEDICAL ADVICE. Every situation is unique, and every
Source: swprs.org On the Treatment of Covid-19 Updated: November 16, 2020; Published: July 2, 2020 Immunological
Results obtained in the prophylaxis of Q fever indicate that chloroquine/hydroxychloroquine can be successfully used in the clinical management of infections other than malaria.
Source: Science Direct Eman Sheshah, Shaun Sabico, Rashed M. Albakr, Anmar A. Sultan, Khalaf S.
Source: Science Direct Simova I, Vekov T, Krasnaliev J, Kornovski V, Bozhinov P,Hydroxychloroquine for prophylaxis
Of the whole study group (RA and SLE), 54% used hydroxychloroquine and 44% had QTc lengths of more than 440 milliseconds. They found that the adjusted QTc length among hydroxychloroquine users was comparable to those who did not use the drug.
Source: Journal of Marine Medical Society Date of Submission 23-Aug-2020 Date of Decision 18-Sep-2020 Date
Source: Science Direct Dr. Deba PrasadDhibarMD(Assistant Professor)aDr. NavneetAroraMD(Senior Resident)aDr. ArpitKakkarDNB(Senior Resident)aDr. NeerajSinglaMD(Assistant Professor)bDr. RitinMohindraMD(Assistant Professor)bDr.
Figure 3 reported random forest for 10 studies comparing HCQ+AZM. Use of the combination HCQ+AZM was associated with 25% lower mortality risk
Source: BioSpace SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 03, 2020 (GLOBE NEWSWIRE) — TLC (Nasdaq:
Source: HCQmeta.com • HCQ is effective for COVID-19. The probability that an ineffective treatment generated
This means that zinc, low dose HCQ, and azithromycin and may prevent a large number of hospitalizations and probably deaths during the SARS-CoV-2 pandemic.
We found a higher survival rate in patients treated with hydroxychloroquine and with macrolides in our study.
This study of critically ill patients with laboratory-confirmed COVID-19 admitted to ICUs in Mexico demonstrated that age and CRP levels upon ICU admission were associated with in-hospital mortality
Author: Vladimir Zev Zelenko M.D. Source Truth stands the test of time. We are currently
Our results can assure that hydroxychloroquine used for COVID-19 patients is safe, highly tolerable, and with minimum side effects.
Hydroxychloroquine, however, was associated with a 53% reduction of being transferred to the ICU.
HCQ has greater efficacy if given earlier in the course of the disease. Several negative studies have been withdrawn due to methodological improprieties.
Australian MPs censored for presenting science. AUSTRALIA: North Queensland MP George Christensen, and the Member
Source: Science Direct A.J.J.LammersaR.M.BrohetbR.E.P.TheunissenaC.KosteraR.RoodcD.W.M.VerhagendK.BrinkmaneR.J.HassingfA.DofferhoffgR.el MoussaouihG.HermanidesiJ.EllerbroekjN.BokhizzoukH.VisserlM.van den BergemH.BaxnD.F.PostmaoP.H.P.Groenevelda aIsala, Zwolle, The NetherlandsbDepartment of Epidemiology and Statistics,
Source: MedRxiv. Full Study in PDF here Xabier Garcia-Albeniz, Julia Del Amo, Rosa Polo, Jose Miguel Morales Asencio, Miguel A HernanmedRxiv 2020.09.29.20203869; doi: https://doi.org/10.1101/2020.09.29.20203869 Abstract Background: There
Source: C19Study A live and ongoing index of studies from around the world documenting the use
In our study, we found hydroxychloroquine wasn’t associated with significant arrhythmia clearly relating to hydroxychloroquine so it seemed the drug was very, very safe
Therefore, Hydroxychloroquine is considered as the first‐line of COVID-19 treatment.
Source: The Lancet Summary Background Hydroxychloroquine is one of several agents being evaluated in the
In this trial, no deaths occurred related to hydroxychloroquine, and serious side effects were rare.
An Urgent Call to Depoliticize Medicine in the COVID-19 Pandemic
HCQ or CQ should be used efficiently alone or in combination with AZ to optimize the management of asymptomatic and mild cases of COVID-19.
Source: Primary Doctor Author: Colleen Huber, NMD Abstract COVID-19 disease is alleged to be caused
Source: Research Gate Conclusions Hydroxychloroquine has been shown to have consistent clinical efficacy for COVID-19
There seems to be a trend towards lower mortality among patients who received treatment with the combination of hydroxychloroquine and azithromycin than among those who did not
Dr. John Campbell Belgium, not Dutch. Low-dose Hydroxychloroquine Therapy and Mortality in Hospitalized Patients with
In this study, SARS-CoV-2 infected non-hospitalized patients hydroxychloroquine exposure was associated with a decreased rate of subsequent hospitalization.
HCQ use was associated with a 30% lower risk of death in COVID-19 hospitalized patients. Our data doesn’t discourage use of HCQ in inpatients with COVID-19.
Source: Science Direct Authors: LucyCatteauPharmD, PhDafi#NicolasDaubyMD, PhDbcdfi#MarionMontourcyMScafiEmmanuelBottieauMD, PhDefiJorisHautekietMScagfiElsGoetghebeurPhDfigSabrinavan IersselMD, PhDfihElsDuysburghMD, MPH, PhDafiHermanVan OyenMD, DrPHafhiChloéWyndham-ThomasMD, PhDafiDominiqueVan
Source: St Vincent’s Hospital Melbourne Healthcare workers are part of the first line of defence
Indeed, following bivariate analysis, hydroxychloroquine/azithromycin treatment was associated with a lower rate of ICU admission (P=0.008).
Source: PubMed. Author: Jean-Michel Scherrmann Scherrmann JM. Possible role of ABCB1 in lysosomal accumulation of
Source: Pandemic War room Jack Maxey and Vish Burra bring you a special edition of
Source: CBS Detroit (CBS DETROIT) – Henry Ford Health System is defending its hydroxychloroquine study showing
HCQ treatment can reduce systemic inflammation and inhibit the cytokine storm, thus protecting multiple organs from inflammatory injuries.
Source: Newsmax An Italian study found that hospitalized coronavirus patients who took anti-malaria drug hydroxychloroquine combined
Indeed, our study suggests that AZI±HCQ might have impacted COVID-19 outcome in a population of patients, optimal timing of treatment interventions to study
hydroxycholoroquine + azithromycin was associated with a 66% reduction in risk of death as compared to controls; the analysis also suggested a larger effectiveness of hydroxychloroquine in patients with less severe COVID-19 disease
Source: c19study.com The studies continue to roll out, and there has been very positive results
Source: Medrxiv.org In this analysis of 1645 patients hospitalized with COVID-19 we find that the
Source: IC Journal Citation: Hong KS, Jang JG, Hur J, Lee JH, Kim HN, Lee
HCQ use significantly reduced the mortality rate, but this association was found only in the lowest cumulative dosage exposure group.
Source: preprints.org Scholz, M.; Derwand, R.; Zelenko, V. COVID-19 Outpatients – Early Risk-Stratified Treatment with
Source: International Journal of Infectious Diseases Highlights As of May27, 2020 there are over 1,678,843
In this study of over 6000 hospitalized patients with COVID-19 in the New York City, hydroxychloroquine use was associated with decreased mortality.
Source: Science Direct Background In our institute in Marseille, France, we initiated early and massive
Source: Vanguard Nigeria Preliminary trials on the use of chloroquine and hydroxychloroquine as prophylaxis for
Source: BioRxiv The pandemic coronavirus COVID-19 affected global health from the end of 2019 to
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
Conclusions: In subjects free of COVID-19, we found a small increase in QTc associated with use of chloroquine, but not hydroxychloroquine. We found no increased mortality associated with use of hydroxychloroquine.
This study provides evidence that (hydroxy)chloroquine may be used effectively in treating moderate COVID-19 and supports larger trials.
Significantly higher rates of discharge home were observed in patients treated by HCQ, a novel finding warranting further confirmation in replicative studies.
None of the patients died in the studied period and only 6 have to be admitted in conventional hospitalization area.
Source: MedRxiv Abstract: The new SARS-CoV-2 infection named COVID-19 has severely hit our Health System.
Source: MedRxiv Abstract Background: While several trials are ongoing for treatment of COVID-19, scientific research
Source: ScienceDirect | PDF of full Journal Pre-Print Abstract In the context of the current
Preface: On May 22, The Lancet published a study of 96,000 COVID-19 patients stating Hydroxychloroquine
Source: Mediterranee Infection COVID-IHU #15 Version 1 du 27 Mai 2020Early diagnosis and management of COVID-19 patients: a real-life cohort study of 3,737 patients,
Source: Zendo In an open letter to MR Mehra, SS Desai, F Ruschitzka, and AN
Source: Oxford Academic – American Journal of Endimology Original unedited manuscript as PDF Abstract More
Source: FOX 2 – Detroit The FDA has warned against taking hydroxychloroquine, but President Trump says
Source: NY1 NEW YORK – Researchers at NYU’s Grossman School of Medicine found patients given
Source: Science Direct Abstract Background In France, the combination hydroxychloroquine (HCQ) and azithromycin (AZ) is
Source: MedRxiv Abstract Importance: Coronavirus disease 2019 (COVID-19) is a pandemic with no specific drugs
SOURCE: The Sun UKDOCTORS in the US have claimed that a now controversial malaria drug
Source: Science Direct PhilippeGautretab1Jean-ChristopheLagierac1PhilippeParolaabVan ThuanHoangabdLineMeddebaJacquesSevestreaMorganeMailheaBarbaraDoudieraCamilleAubryaSophieAmraneaPisethSengaMarieHocquartaCaroleEldinabJulieFinanceeVera EstevesVieiraaHervé TissotTissot-DupontacStéphaneHonoréfgAndreasSteinacMatthieuMillionacPhilippeColsonacBernardLa ScolaacVéroniqueVeithAlexisJacquieriJean-ClaudeDeharojMichelDrancourtacPierre EdouardFournierabJean-MarcRolainacPhilippeBrouquiacDidierRaoultac aIHU-Méditerranée Infection, Marseille, France bAix Marseille
Source: Tech Startups Peak Prosperity April 8 Update: More doctors are now saying Hydroxychloroquine only works
Source: A few days ago, Dr. Ciro Maguiña highlighted the positive effects of the use
Source: Ala Arena In a press conference, the Minister of Health, Mario Kohan, informed that
Source: The Malaysian Insight THE Health Ministry is in the midst of developing clinical trials
The FLCCC Alliance was organized in March, 2020 by a group of highly published, world renowned Critical Care physician/scholars – with the academic support of allied physicians from around the world – to research and develop lifesaving protocols for the prevention and treatment of COVID-19 in all stages of illness.
Source: Trial Site News Author: Mary Beth Pfeiffer Withholding ivermectin as a treatment for COVID-19
Source: Quadrant Online Author: Robert Clancy Robert Clancy: The author is Emeritus Professor of Pathology
This is the story of a 80-year-old Buffalo woman who became critically ill with COVID-19. Her family begged for the hospital to give her ivermectin.
A Utah pharmacist accused of illegally receiving a controversial coronavirus drug “had a green light from a lot of very prominent Utah authorities to do exactly what he did,” his defense attorney asserts.
The Palmer Foundation is the philanthropic entity owned by the Palmer family, headed by Clive Palmer.
The Palmer Foundation is a private entity that engages in charitable projects that enable better welfare of others, and society as a whole.
The foundations most recent endeavour revolves around the response to, and action on the COVID-19 Virus pandemic for the treatment of all Australians in need.
Click here to get the background on The Palmer Foundations COVID-19 Response.
Source: Research Gate SHOUMAN WM1, HEGAZY AA2, NAFAE RM3, RAGAB ME4, SAMRA SR5, ANAS D6,
Source: A few days ago, Dr. Ciro Maguiña highlighted the positive effects of the use
Source: Ala Arena In a press conference, the Minister of Health, Mario Kohan, informed that
Source: The Malaysian Insight THE Health Ministry is in the midst of developing clinical trials